The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Biomarkers for the lung cancer diagnosis and their advances in proteomics
Open accessAbstract
Over a last decade, intense interest has been focused on biomarker discovery and their clinical uses. This interest is accelerated by the completion of human genome project and the progress of techniques in proteomics. Especially, cancer biomarker discovery is eminent in this field due to its anticipated critical role in early diagnosis, therapy guidance, and prognosis monitoring of cancers. Among cancers, lung cancer, one of the top three major cancers, is the one showing the highest mortality because of failure in early diagnosis. Numerous potential DNA biomarkers such as hypermethylations of the promoters and mutations in K-ras, p53, and protein biomarkers; carcinoembryonic antigen (CEA), CYFRA21-1, plasma kallikrein B1 (KLKB1), Neuron-specific enolase, etc. have been discovered as lung cancer biomarkers. Despite extensive studies thus far, few are turned out to be useful in clinic. Even those used in clinic do not show enough sensitivity, specificity and reproducibility for general use. This review describes what the cancer biomarkers are for, various types of lung cancer biomarkers discovered at present and predicted future advance in lung cancer biomarker discovery with proteomics technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Cited by
Adamczyk, B., Tharmalingam, T., & Rudd, P. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.001 · Cited by 478
Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
Hanash, S. M., Baik, C. S., & Kallioniemi, O. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.220 · Cited by 328
Washburn, A. L., Gunn, L. C., & Bailey, R. C. (2009) · Analytical Chemistry · doi:10.1021/ac902006p · Cited by 318
Exhaled biomarkers in lung cancer
Horváth, I., Lázár, Z., Gyulai, N., Kollai, M., & Losonczy, G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00142508 · Cited by 268
The cancer cell secretome: A good source for discovering biomarkers?
Pavlou, M. P., & Diamandis, E. P. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.04.003 · Cited by 200
Forshed, J., Johansson, H. J., Pernemalm, M., Branca, R. M. M., Sandberg, A., & Lehtiö, J. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010264 · Cited by 32
Metadata
- Authors
- Sung, H.-J., & Cho, J.-Y.
- Venue
- BMB Reports
- Published
- 2008-09-30
- Volume
- 41
- Issue
- 9
- Pages
- 615-625
- ISSN
- 1976-6696 (ISSN-L)
- OpenAlex
- W1964064441
- Cited by
- 161
- References
- 3
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.